Can deep learning effectively diagnose cardiac amyloidosis with 99mTc-PYP scintigraphy?
Journal of Radioanalytical and Nuclear Chemistry, ISSN: 1588-2780, Vol: 334, Issue: 1, Page: 1033-1048
2025
- 3Citations
- 1Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
This study investigates the effectiveness of deep learning models in diagnosing cardiac amyloidosis using 99mTc-PYP scintigraphy. We evaluated more than 40 deep learning models, including both convolutional neural networks (CNNs) and Vision Transformer (ViT) models. The highest-performing model achieved 89.80% accuracy. The study highlights the potential of deep learning methods to improve diagnostic accuracy and reduce patient wait times. These results demonstrate the clinical value of deep learning models in early and accurate cardiac amyloidosis diagnosis, contributing to better patient outcomes and timely interventions.
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know